Frontotemporal dementia (FTD), a common form of early-onset dementia, is often misdiagnosed due to its overlapping symptoms with psychiatric and neurological disorders. In a new NIH-funded study, researchers identified key protein changes in spinal fluid that may serve as the first specific biomarkers for FTD in living patients.
Frontotemporal dementia (FTD), a common form of early-onset dementia, is often misdiagnosed due to its overlapping symptoms with psychiatric and neurological disorders. In a new NIH-funded study, researchers identified key protein changes in spinal fluid that may serve as the first specific biomarkers for FTD in living patients.
Share this Article
Recommended